Bicycle Therapeutics (BCYC) News Today $8.09 +0.09 (+1.13%) Closing price 04:00 PM EasternExtended Trading$8.01 -0.08 (-1.05%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCYC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Kevin Lee Sells 2,268 Shares of Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) StockJuly 8 at 4:53 AM | insidertrades.comInsider Selling: Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) CEO Sells 2,268 Shares of StockJuly 7 at 6:40 PM | marketbeat.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) CEO Kevin Lee Sells 3,193 SharesJuly 7 at 6:40 PM | marketbeat.comBicycle Therapeutics plc (BCYC) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) - MorningstarJuly 4, 2025 | morningstar.comMBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJuly 4, 2025 | americanbankingnews.comBicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 4, 2025 | marketbeat.comBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 2, 2025 | businesswire.comBicycle Therapeutics (NASDAQ:BCYC) Shares Up 7.6% - Still a Buy?July 2, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Shares Gap Up - What's Next?June 20, 2025 | marketbeat.comIs Bicycle Therapeutics (NASDAQ:BCYC) In A Good Position To Invest In Growth?June 14, 2025 | finance.yahoo.comBicycle Therapeutics (NASDAQ:BCYC) Stock Price Down 4.6% - Time to Sell?June 13, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Shares Up 5.5% - Time to Buy?June 11, 2025 | marketbeat.comAnalysts Issue Forecasts for BCYC FY2026 EarningsJune 10, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesJune 9, 2025 | marketbeat.comFarewell To Bruno: ‘Bicycle Thieves’ Child Star Enzo Staiola Dies At 85June 8, 2025 | msn.comVictorville streets closing Sunday near City Hall for Majestic Cycling Bicycle Road RaceJune 8, 2025 | msn.comBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 3, 2025 | businesswire.comMillennium Management LLC Invests $2.48 Million in Bicycle Therapeutics plc (NASDAQ:BCYC)June 1, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Stock Price Down 4.6% - Here's WhyMay 31, 2025 | marketbeat.comBicycle Therapeutics (NASDAQ:BCYC) Stock Price Up 5.5% - Still a Buy?May 30, 2025 | marketbeat.comBicycle Therapeutics’ SWOT analysis: stock faces pivotal phase amid clinical progressMay 28, 2025 | uk.investing.comBicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual MeetingMay 22, 2025 | businesswire.comBicycle Therapeutics plc (NASDAQ:BCYC) Stock Position Trimmed by Tybourne Capital Management HK Ltd.May 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Acquires 3,655,101 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)May 18, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Given Average Rating of "Moderate Buy" by AnalystsMay 17, 2025 | marketbeat.comParkman Healthcare Partners LLC Sells 92,915 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)May 16, 2025 | marketbeat.comBCYC FY2025 EPS Estimate Lowered by Cantor FitzgeraldMay 13, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Stock Position Decreased by Schonfeld Strategic Advisors LLCMay 12, 2025 | marketbeat.comFcpm Iii Services B.V. Has $48.33 Million Stock Position in Bicycle Therapeutics plc (NASDAQ:BCYC)May 11, 2025 | marketbeat.comVoya Investment Management LLC Lowers Position in Bicycle Therapeutics plc (NASDAQ:BCYC)May 11, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Shares Sold by Deep Track Capital LPMay 9, 2025 | marketbeat.comCaption Management LLC Purchases New Position in Bicycle Therapeutics plc (NASDAQ:BCYC)May 9, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for BCYC FY2029 Earnings?May 7, 2025 | marketbeat.comBicycle Therapeutics plc (NASDAQ:BCYC) Stock Position Increased by Baker BROS. Advisors LPMay 6, 2025 | marketbeat.comBicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 5, 2025 | businesswire.comBicycle Therapeutics (NASDAQ:BCYC) Posts Earnings Results, Misses Expectations By $0.02 EPSMay 5, 2025 | marketbeat.comIs Bicycle Therapeutics plc (BCYC) the Best Small Cap Stock to Buy with the Biggest Upside Potential?May 5, 2025 | insidermonkey.comA Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 AnalystsMay 4, 2025 | nasdaq.comBicycle Therapeutics (NASDAQ:BCYC) Price Target Cut to $22.00 by Analysts at JMP SecuritiesMay 4, 2025 | marketbeat.comBicycle Therapeutics' (BCYC) Buy Rating Reaffirmed at Needham & Company LLCMay 4, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 136,913 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)May 4, 2025 | marketbeat.comB.Riley Financial Sticks to Their Hold Rating for Bicycle Therapeutics (BCYC)May 4, 2025 | theglobeandmail.comRA Capital Management L.P. Sells 1,159,523 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)May 3, 2025 | marketbeat.comBarclays Sticks to Its Buy Rating for Bicycle Therapeutics (BCYC)May 3, 2025 | theglobeandmail.comBicycle Therapeutics plc (NASDAQ:BCYC) Sees Significant Decline in Short InterestMay 3, 2025 | marketbeat.comBicycle Therapeutics price target lowered to $15 from $40 at BarclaysMay 2, 2025 | finance.yahoo.comBicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025May 1, 2025 | seekingalpha.comBicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial ResultsMay 1, 2025 | finance.yahoo.comLegal & General Group Plc Has $1.95 Million Stake in Bicycle Therapeutics plc (NASDAQ:BCYC)April 27, 2025 | marketbeat.com Get Bicycle Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCYC and its competitors with MarketBeat's FREE daily newsletter. Email Address BCYC Media Mentions By Week BCYC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCYC News Sentiment▼0.000.57▲Average Medical News Sentiment BCYC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCYC Articles This Week▼155▲BCYC Articles Average Week Get Bicycle Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CG Oncology News Today Kiniksa Pharmaceuticals International News Today Beam Therapeutics News Today IDEAYA Biosciences News Today Disc Medicine News Today Belite Bio News Today Centessa Pharmaceuticals News Today Harmony Biosciences News Today Adaptive Biotechnologies News Today Sarepta Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCYC) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
